Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Victor Skriver

Equity Research Assistant

Victor Skriver portrait

Latest content

ShowingAll content types

Lundbeck (Investeringscase): Stærkt H1 2026 med vækst, nedgearing og fremrykkede katalysatorer

Research 04.09.2026, 14.15 by Michael Friis, Victor Skriver
Lundbeck

BioPorto: Q2 delivered on all parameters set out in the long-term plan

Research 03.09.2026, 15.45 by Michael Friis, Victor Skriver
BioPorto

Dagens aktienyheder 03/09/2026: ExpreS2ion Biotech, Skjern Bank

Analyst Comment 03.09.2026, 09.00 by Victor Skriver
Skjern BankExpreS2ion Biotech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

HCA Morgenbørs 02/09 - Novo Nordisk vs. Eli Lilly med Claus Johansen og dagens aktiemarked

Video 02.09.2026, 09.31 by Jacob Frehr, Victor Skriver
Novo NordiskSchouw & CoMatasFreetrailer Group

Today's stock news 02/09/2026: Gabriel and GomSpace

Analyst Comment 02.09.2026, 08.54 by Rasmus Køjborg, Victor Skriver
Gabriel HoldingGomSpace

Guidance narrows despite a solid Q3 2025/26 margin

Research 02.09.2026, 08.30 by Rasmus Køjborg, Victor Skriver
Gabriel Holding

Dagens aktienyheder 01/09/2026: North Media og Hafnia

Analyst Comment 01.09.2026, 09.05 by Victor Skriver
HafniaNorth Media

Dagens aktienyheder 31/08/2026: Pharma Equity Group, Curasight og Columbus

Analyst Comment 31.08.2026, 09.08 by Victor Skriver
Pharma Equity GroupColumbusCurasight

Columbus (Investment Case): AI moving from delivery efficiency into the revenue model

Research 31.08.2026, 09.00 by Michael Friis, Victor Skriver
Columbus

Mød ledelsen i Curasight og Impero og stil dine spørgsmål til dagens investorpræsentationer

Analyst Comment 31.08.2026, 08.30 by Victor Skriver
CurasightImpero